{"nctId":"NCT04392362","briefTitle":"A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)","startDateStruct":{"date":"2018-04-01","type":"ACTUAL"},"conditions":["Supra-ventricular Tachycardia"],"count":30,"armGroups":[{"label":"Intervention group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Adenosine"]},{"label":"Control group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Adenosine"]}],"interventions":[{"name":"Adenosine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Svt\n* normal blood pressure\n* normal mentation\n* Give consent\n\nExclusion Criteria:\n\n* recent coffee\n* Allergy to adenosine\n* Asthma\n* cardiac operations","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Number of Patients With First Dose Successful Termination of the Supraventricular Tachycardia to a Sinus Rhythm of Less Than 140 With the AHA Versus a Simplified Method of Adenosine Administration","description":"The primary outcome is the rhythm of conversion to a sinus rhythm less than 140 beat per minute.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":23},"commonTop":["Feeling of impending doom, dizziness"]}}}